Resultats de la cerca - Richard D. Wasnich

  • Mostrar 1 - 11 resultats de 11
Refinar resultats
  1. 1
    Antifracture Efficacy of Antiresorptive Agents Are Related to Changes in Bone Density

    Antifracture Efficacy of Antiresorptive Agents Are Related to Changes in Bone Density per Richard D. Wasnich, Paul D. Miller

    Publicat 2000
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    The effect of long-distance running upon appendicular bone mineral content

    The effect of long-distance running upon appendicular bone mineral content per JUDITH ANN WILLIAMS, John J. Wagner, Richard D. Wasnich, Lance K. Heilbrun

    Publicat 1984
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Effect of thiazide on rates of bone mineral loss: a longitudinal study.

    Effect of thiazide on rates of bone mineral loss: a longitudinal study. per Richard D. Wasnich, J. W. Davis, Philip D. Ross, John M. Vogel

    Publicat 1990
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    The Effects of Smoking on Bone Mass and the Rates of Bone Loss Among Elderly Japanese-American Men

    The Effects of Smoking on Bone Mass and the Rates of Bone Loss Among Elderly Japanese-American Men per John M. Vogel, James W. Davis, Abraham M. Y. Nomura, Richard D. Wasnich, Philip D. Ross

    Publicat 1997
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Changes in Bone Density and Turnover Explain the Reductions in Incidence of Nonvertebral Fractures that Occur during Treatment with Antiresorptive Agents

    Changes in Bone Density and Turnover Explain the Reductions in Incidence of Nonvertebral Fractures that Occur during Treatment with Antiresorptive Agents per Marc C. Hochberg, Susan L. Greenspan, Richard D. Wasnich, Paul D. Miller, Desmond Thompson, Philip D. Ross

    Publicat 2002
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  6. 6
    Monitoring of Alendronate Treatment and Prediction of Effect on Bone Mass by Biochemical Markers in the Early Postmenopausal Intervention Cohort Study1

    Monitoring of Alendronate Treatment and Prediction of Effect on Bone Mass by Biochemical Markers in the Early Postmenopausal Intervention Cohort Study1 per Pernille Ravn, D. J. Hosking, Desmond Thompson, Giovanni Cizza, Richard D. Wasnich, Michael R. McClung, A.J.P. Yates, N. H. Bjarnason, Claus Christiansen

    Publicat 1999
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Prevention of Postmenopausal Bone Loss: Six-Year Results from the Early Postmenopausal Intervention Cohort Study

    Prevention of Postmenopausal Bone Loss: Six-Year Results from the Early Postmenopausal Intervention Cohort Study per Michael R. McClung, Richard D. Wasnich, David Hosking, Claus Christiansen, Pernille Ravn, Mei Wu, Ann Marie Mantz, John Yates, Philip D. Ross, Arthur C. Santora

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age

    Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age per David Hosking, Clair E.D. Chilvers, Claus Christiansen, Pernille Ravn, Richard D. Wasnich, Philip D. Ross, Michael R. McClung, Ana Balske, Desmond Thompson, Marianne Daley, A.J.P. Yates

    Publicat 1998
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Alendronate in Early Postmenopausal Women: Effects on Bone Mass during Long-Term Treatment and after Withdrawal<sup>1</sup>

    Alendronate in Early Postmenopausal Women: Effects on Bone Mass during Long-Term Treatment and after Withdrawal<sup>1</sup> per Pernille Ravn, Stuart Weiss, Jose Adolfo Rodriguez-Portales, Michael R. McClung, Richard D. Wasnich, Nigel Gilchrist, Philip N. Sambrook, Ignac Fogelman, David Krupa, A.J.P. Yates, Anastasia G. Daifotis, Ghada El‐Hajj Fuleihan

    Publicat 2000
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Effect of Risedronate on the Risk of Hip Fracture in Elderly Women

    Effect of Risedronate on the Risk of Hip Fracture in Elderly Women per Michael R. McClung, Piet Geusens, Paul D. Miller, H Zippel, W. Bensen, Christian Roux, Silvano Adami, Ignac Fogelman, Terrence Diamond, Richard Eastell, Pierre J. Meunier, Richard D. Wasnich, Maria Greenwald, Jean‐Marc Kaufman, Charles H. Chesnut, Jean‐Yves Reginster

    Publicat 2001
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  11. 11
    Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis

    Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis per Nelson B. Watts, Steven T. Harris, Harry K. Genant, Richard D. Wasnich, Paul D. Miller, Rebecca D. Jackson, Angelo A. Licata, Philip D. Ross, Grattan C. Woodson, M. Yanover, W. Jerry Mysiw, Larry M. Kohse, MK Rao, Peter Steiger, Bradford J. Richmond, Charles H. Chesnut

    Publicat 1990
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: